Eisai, Merck stave off generic competition to Lenvima
Eisai and Merck succeeded in stopping Shilpa Medicare Ltd. from launching a generic version of Lenvima for at least another decade, Eisai said Thursday. The Japanese pharma company said it received a “favorable decision” from ...
Eisai and Merck succeeded in stopping Shilpa Medicare Ltd. from launching a generic version of Lenvima for at least another decade, Eisai said Thursday.
The Japanese pharma company said it received a “favorable decision” from ...
